Adenosine, an endogenous distress signal, modulates tissue damage and repair

Adenosine is formed inside cells or on their surface, mostly by breakdown of adenine nucleotides. The formation of adenosine increases in different conditions of stress and distress. Adenosine acts on four G-protein coupled receptors: two of them, A1 and A3, are primarily coupled to Gi family G proteins; and two of them, A2A and A2B, are mostly coupled to Gs like G proteins. These receptors are antagonized by xanthines including caffeine. Via these receptors it affects many cells and organs, usually having a cytoprotective function. Joel Linden1 recently grouped these protective effects into four general modes of action: increased oxygen supply/demand ratio, preconditioning, anti-inflammatory effects and stimulation of angiogenesis. This review will briefly summarize what is known and what is not in this regard. It is argued that drugs targeting adenosine receptors might be useful adjuncts in many therapeutic approaches.

[1]  I. Biaggioni,et al.  Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A2B Angiogenic Phenotype , 2004, Hypertension.

[2]  R. Bolli,et al.  Delayed Adaptation of the Heart to Stress: Late Preconditioning , 2004, Stroke.

[3]  G. Hartmann,et al.  Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. , 2004, Blood.

[4]  C. Müller,et al.  Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs. , 2006, Current topics in medicinal chemistry.

[5]  S. Colgan,et al.  Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. , 2004, Blood.

[6]  A. Ohta,et al.  Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung Injury , 2005, PLoS biology.

[7]  R. Berne Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. , 1963, The American journal of physiology.

[8]  Seiko F. Okada,et al.  Physiological Regulation of ATP Release at the Apical Surface of Human Airway Epithelia*♦ , 2006, Journal of Biological Chemistry.

[9]  E. Monteiro,et al.  Adenosine-dopamine interactions and ventilation mediated through carotid body chemoreceptors. , 2000, Advances in experimental medicine and biology.

[10]  B. Fredholm Chapter 11 Adenosine and Neuroprotection , 1996 .

[11]  R. Boucher,et al.  Ecto 5′-Nucleotidase and Nonspecific Alkaline Phosphatase , 2003, The Journal of Biological Chemistry.

[12]  Hongyan Zhong,et al.  Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. , 2006, The Journal of clinical investigation.

[13]  Courtney M. Lappas,et al.  A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. , 2005, Journal of immunology.

[14]  B. Fredholm,et al.  Adenosine A1 receptors are crucial in keeping an epileptic focus localized , 2006, Experimental Neurology.

[15]  J. Schrader,et al.  Cardiac adenosine production is linked to myocardial pO2. , 1991, Journal of molecular and cellular cardiology.

[16]  M. Bours,et al.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.

[17]  H. Zimmermann Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  P. MacDonald,et al.  Release of small transmitters through kiss-and-run fusion pores in rat pancreatic beta cells. , 2006, Cell metabolism.

[19]  O. Feron,et al.  Innate immunity and angiogenesis. , 2004, Circulation research.

[20]  J. Schnermann,et al.  A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. , 2005, The Journal of clinical investigation.

[21]  M. Blackburn,et al.  Adenosine signaling in asthma and chronic obstructive pulmonary disease , 2006, Current opinion in pulmonary medicine.

[22]  B. Fredholm,et al.  Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. , 1999, Pharmacological reviews.

[23]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[24]  A. Zernecke,et al.  CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation , 2006, Circulation.

[25]  B. Fredholm,et al.  Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro , 2004, The European journal of neuroscience.

[26]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[27]  K. Chergui,et al.  NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A1 receptors: Evidence from knockout mice , 2006, Neuropharmacology.

[28]  S. Robson,et al.  Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. , 2005, Seminars in thrombosis and hemostasis.

[29]  B. Fredholm,et al.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Fredholm,et al.  Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate , 2002, The European journal of neuroscience.

[31]  F. Northington,et al.  Differential expression of A2a, A1-adenosine and D2-dopamine receptor genes in rat peripheral arterial chemoreceptors during postnatal development , 2000, Brain Research.

[32]  J. Schnermann,et al.  Role of A1 adenosine receptors in regulation of vascular tone. , 2005, American journal of physiology. Heart and circulatory physiology.

[33]  M. Moskowitz,et al.  Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury , 2004, Nature Medicine.

[34]  M. Koupenova,et al.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. , 2006, The Journal of clinical investigation.

[35]  J. Linden,et al.  A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. , 2004, The Journal of infectious diseases.

[36]  A. Ohta,et al.  Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo , 2004, The Journal of Immunology.

[37]  P. Kochanek,et al.  Adenosine A1 Receptor Knockout Mice Develop Lethal Status Epilepticus after Experimental Traumatic Brain Injury , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  B. Fredholm,et al.  Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[39]  B. Fredholm,et al.  Aspects of the general biology of adenosine A2A signaling , 2007, Progress in Neurobiology.

[40]  B. Fredholm Purines and neutrophil leukocytes. , 1997, General pharmacology.

[41]  A. Gerbes,et al.  [Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage]. , 2002, Zeitschrift fur Gastroenterologie.

[42]  J. Headrick,et al.  Acute adenosinergic cardioprotection in ischemic-reperfused hearts. , 2003, American journal of physiology. Heart and circulatory physiology.

[43]  Raphaelle Winsky-Sommerer,et al.  Transgenic Mice with a Reduced Core Body Temperature Have an Increased Life Span , 2006, Science.

[44]  F. Northington,et al.  Differential expression of a(2a), A(1)-adenosine and D(2)-dopamine receptor genes in rat peripheral arterial chemoreceptors during postnatal development. , 2000, Brain research.

[45]  J. Linden Adenosine in Tissue Protection and Tissue Regeneration , 2005, Molecular Pharmacology.

[46]  J. Schnermann,et al.  Vasoconstrictor and vasodilator effects of adenosine in the kidney. , 2003, American journal of physiology. Renal physiology.

[47]  R. Fryer,et al.  Therapeutic receptor targets of ischemic preconditioning. , 2002, Cardiovascular research.

[48]  B. Fredholm,et al.  Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A1 receptors , 2007, Acta physiologica.

[49]  Linda Yip,et al.  ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.

[50]  S. Colgan,et al.  ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function , 2006, Circulation research.

[51]  B. Fredholm,et al.  Anoxia redistributes adenosine A2A receptors in PC12 cells and increases receptor-mediated formation of cAMP , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[52]  M. Hershfield New insights into adenosine‐receptor‐mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency , 2005, European journal of immunology.

[53]  S. Schiffmann,et al.  Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor , 1997, Nature.

[54]  B. Fredholm Adenosine and neuroprotection. , 1997, International review of neurobiology.

[55]  E. Vizi,et al.  Shaping of monocyte and macrophage function by adenosine receptors. , 2007, Pharmacology & therapeutics.

[56]  K. Jin,et al.  From angiogenesis to neuropathology , 2005, Nature.

[57]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[58]  B. Cronstein Adenosine, an endogenous anti-inflammatory agent. , 1994, Journal of applied physiology.

[59]  B. Fredholm,et al.  Adenosine A1 receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia , 2004 .

[60]  D. Chung,et al.  Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-δ pathway activation , 2006 .

[61]  B. Fredholm,et al.  Synergistic Effects of Adenosine A1 and P2Y Receptor Stimulation on Calcium Mobilization and PKC Translocation in DDT1 MF-2 Cells , 2003, Cellular and Molecular Neurobiology.

[62]  Courtney M. Lappas,et al.  Adenosine A2A agonists in development for the treatment of inflammation , 2005, Expert opinion on investigational drugs.

[63]  Tianxin Yang,et al.  Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. Colgan,et al.  The FASEB Journal • Research Communication HIF-dependent induction of adenosine A2B receptor in hypoxia , 2022 .

[65]  D. Boison Adenosine kinase, epilepsy and stroke: mechanisms and therapies. , 2006, Trends in pharmacological sciences.

[66]  A. Ohta,et al.  A2A adenosine receptor protects tumors from antitumor T cells , 2006, Proceedings of the National Academy of Sciences.

[67]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[68]  Courtney M. Lappas,et al.  Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation , 2006, The Journal of experimental medicine.

[69]  Lu-Yuan Lee,et al.  Hypersensitivity of pulmonary C fibers induced by adenosine in anesthetized rats. , 2003, Journal of applied physiology.

[70]  B. Fredholm,et al.  Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. , 2005, Annual review of pharmacology and toxicology.

[71]  W. Xiong,et al.  Astrocytes and neurons: different roles in regulating adenosine levels , 2005, Neurological research.

[72]  H G Lloyd,et al.  Contribution of S-adenosylhomocysteine to cardiac adenosine formation. , 1989, Journal of molecular and cellular cardiology.

[73]  M. Moskowitz,et al.  A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice , 1999, The Journal of Neuroscience.

[74]  K. Varani,et al.  Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells. , 2006, Biochemical pharmacology.

[75]  M. Caruso,et al.  Adenosine signalling in airways. , 2006, Current opinion in pharmacology.

[76]  H. Yee,et al.  Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. , 2004, The American journal of pathology.

[77]  R. Boucher,et al.  A1 antagonism in asthma: better than coffee? , 2005, The Journal of clinical investigation.

[78]  T. Adair Growth regulation of the vascular system: an emerging role for adenosine. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[79]  B. Fredholm,et al.  Release of Purines, Noradrenaline, and GABA from Rat Hippocampal Slices by Field Stimulation , 1985, Journal of neurochemistry.

[80]  B. Fredholm,et al.  Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. , 2006, American journal of physiology. Heart and circulatory physiology.

[81]  M. Sherman,et al.  Multiple Thermometers in Mammalian Cells: Why Do Cells from Homeothermic Organisms Need to Measure Temperature? , 2006, Science's STKE.

[82]  C. Power,et al.  A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple Sclerosis , 2004, The Journal of Neuroscience.